Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Ventyx Biosciences, Inc. (VTYX) Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug